An in silico transwell device for the study of drug transport and drug - Drug interactions

Pharmaceutical Research

Volumn 24, Issue 12, 2007, Pages 2171-2186

  Garmire, Lana X ^a   Garmire, David G ^a   Hunt, C Anthony ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Agent based modeling; Discrete event; Drug transport; Drug drug interaction; Emergent properties; Simulation

Indexed keywords

ALFENTANIL; ENZYME; UREA;

ARTICLE; COMPUTER MODEL; COMPUTER PROGRAM; DEVICE; DRUG TRANSPORT; IN VITRO STUDY; KINETICS; PH MEASUREMENT; PRIORITY JOURNAL;

ALFENTANIL; ANALGESICS, OPIOID; ANIMALS; BIOLOGICAL TRANSPORT; CATALYTIC DOMAIN; CELL MEMBRANE; COMPUTER SIMULATION; DIFFUSION; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; ENZYMES; EQUIPMENT DESIGN; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MODELS, BIOLOGICAL; OXAZINES; PHARMACEUTICAL PREPARATIONS; REPRODUCIBILITY OF RESULTS; SOFTWARE; TECHNOLOGY, PHARMACEUTICAL; TIGHT JUNCTIONS; UREA;

EID: 35848941160     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9391-4     Document Type: Article

References (31)

1. Y. Liu and C. A. Hunt. Studies of intestinal drug transport using an in silico epithelio-mimetic device. Biosystems 82:154-167 (2005).
2. Y. Liu and C. A. Hunt. Mechanistic study of the cellular interplay of transport and metabolism using the synthetic modeling method. Pharm. Res. 23:493-505 (2006).
3. G. E. Ropella, C. A. Hunt, and D. A. Nag. Using heuristic models to bridge the gap between analytic and experimental models in biology. In L. Yilmaz (ed), Agent-Directed Simulation Symposium, Vol. Simulation Series 37(2) (ADS'05). SCS Press, San Diego, CA, 2005, pp. 182-190.
4. G. E. P. Ropella, C. A. Hunt, and S. Sheikh-Bahaei. Methodological considerations of heuristic modeling of biological systems. 9th World Multi-Conference on Systemics, Cybernetics and Informatics, Orlando, FL, 2005.
5. C. A. Hunt, G. E. Ropella, L. Yan, D. Y. Hung, and M. S. Roberts. Physiologically based synthetic models of hepatic disposition. J. Pharmacokinet. Pharmacodyn. 33:737-772 (2006).
6. S. Sheikh-Bahaei and C. A. Hunt. Prediction of in vitro hepatic biliary excretion using stochastic agent-based modeling and fuzzy clustering. In: L. F. Perrone et al. (eds.), Proc. of the 37th Conference on Winter Simulation, 1617-24 (2006).
7. S. Railsback et al. Agent-based simulation platforms: review and development recommendations. Simulation 82:609-623 (2006).
8. G. T. Knipp, N. F. Ho, C. L. Barsuhn, and R. T. Borchardt. Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. J. Pharm. Sci. 86:1105-1110 (1997).
9. R. Hine. Membrane, The Facts on File Dictionary of Biology, Checkmark, New York, 1999, pp. 198.
10. P. Ball. Introduction to discrete event simulation, 2nd DYCOMANS workshop on "Management and Control: Tools in Action," Algarve, Portugal, 1996, pp. 367-76.
11. T. H. Cormen, C. E. Leiserson, and R. L. Rivest. Introduction to algorithms, McGraw-Hill, New York, 1990.
12. G. Camenisch, G. Folkers, and H. van de Waterbeemd. Review of theoretical passive drug absorption models: historical background, recent developments and limitations. Pharm. Acta Helv. 71:309-327 (1996).
13. K. Palm, K. Luthman, J. Ros, J. Grasjo, and P. Artursson. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. J. Pharmacol. Exp. Ther. 291:435-443 (1999).
14. K. Obata, K. Sugano, R. Saitoh, A. Higashida, Y. Nabuchi, M. Machida, and Y. Aso. Prediction of oral drug absorption in humans by theoretical passive absorption model. Int. J. Pharm. 293:183-192 (2005).
15. S. Narasimhulu. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling). Biochim. Biophys. Acta 1770:360-375 (2007).
16. W. M. Atkins. Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions. Annu. Rev. Pharmacol. Toxicol. 45:291-310 (2005).
17. M. Shou, Y. Lin, P. Lu, C. Tang, Q. Mei, D. Cui, W. Tang, J. S. Ngui, C. C. Lin, R. Singh, B. K. Wong, J. A. Yergey, J. H. Lin, P. G. Pearson, T. A. Baillie, A. D. Rodrigues, and T. H. Rushmore. Enzyme kinetics of cytochrome P450-mediated reactions. Current Drug Metabolism 2:17-36 (2001).
18. K. R. Korzekwa, N. Krishnamachary, M. Shou, A. Ogai, R. A. Parise, A. E. Rettie, F. J. Gonzalez, and T. S. Tracy. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 37:4137-4147 (1998).
19. G. Camenisch, G. Folkers, and H. van de Waterbeemd. Shapes of membrane permeability-lipophilicity curves: extension of theoretical models with an aqueous pore pathway. Eur. J. Pharm. Sci. 6:325-329 (1998).
20. H. Lennernas. Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation? Pharm. Res. 12:1573-1582 (1995).
21. P. Artursson, K. Palm, and K. Luthman. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 46:27-43 (2001).
22. Defense Modeling and Simulation Office, United States Department of Defense. Online M&S Glossary. https://www.dmso.mil/public/resources/ glossary/, Cited 3/27/07. Part of the Defense Modeling and Simulation Office Web site, https://www.dmso.mil/public/, Cited 3/27/07.
23. A. Avdeef. Physicochemical profiling (solubility, permeability and charge state). Curr. Top. Med. Chem. 1:277-351 (2001).
24. A. Barat, H. J. Ruskin, and M. Crane. Probabilistic models for drug dissolution. Part 1. Review of Monte Carlo and stochastic cellular automata approaches. Simul. Model. Pract. Theory 14:843-856 (2006).
25. V. Grimm, E. Revilla, U. Berger, F. Jeltsch, W. M. Mooij, S. F. Railsback, H. H. Thulke, J. Weiner, T. Wiegand, and D. L. DeAngelis. Pattern-oriented modeling of agent-based complex systems: lessons from ecology. Science 310:987-991 (2005).
26. B. Faller. Enhancing knowledge through combination of in-silico and in-vitro ADME profiling assays, 1st annual phys. chem. symposium: early ADME and medical chemistry, Obernai, France, (2004). http://www.acdlabs.com/download/ publ/2004/eum04/adme.pdf/. Cited 3/27/07.
27. R. Schulz and D. Winne. Relationship between antipyrine absorption and blood flow rate in rat jejunum, ileum, and colon. Naunyn-Schmiedeberg's Arch. Pharmacol. 335:97-102 (1987).
28. N. Mork, H Bundgaard, M Shalmi, S Christensen. Furosemide prodrugs: synthesis, enzymatic hydrolysis and solubility of various furosemide esters. Int. J. Pharm. 60:163-169 (1990).
29. M. R. Grant, K. E. Mostov, T. D. Tlsty, and C. A. Hunt. Simulating properties of in vitro epithelial cell morphogenesis. PLoS Comput. Biol. 2:e129 (2006).
30. J. Tang, K. F. Ley, and C. A. Hunt. Dynamics of in silico leukocyte rolling, activation, and adhesion. BMC Syst. Biol. 1:14 (2007).
31. B. P. Zeigler, H. Praehofer, and T. G. Kim. Theory of modeling and simulation: integrating discrete event and continuous complex dynamic systems, Academic, San Diego, 2000.